EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 0.0156
March 31, 2026 -0.2434
December 31, 2025 -0.4371
September 30, 2025 0.0513
June 30, 2025 -0.0527
March 31, 2025 -0.0693
December 31, 2024 -0.0271
September 30, 2024 0.1262
June 30, 2024 -0.1443
March 31, 2024 0.1886
December 31, 2023 0.8073
September 30, 2023 0.0784
June 30, 2023 0.2536
March 31, 2023 -0.0005
December 31, 2022 -0.1023
September 30, 2022 0.0599
June 30, 2022 0.0526
March 31, 2022 0.0632
December 31, 2021 -0.0423
September 30, 2021 0.0665
June 30, 2021 0.0968
March 31, 2021 0.086
December 31, 2020 0.1686
September 30, 2020 0.0465
June 30, 2020 0.0234
Date Value
March 31, 2020 0.0272
December 31, 2019 -0.0208
September 30, 2019 0.0215
June 30, 2019 0.0129
March 31, 2019 0.0258
December 31, 2018 -0.0289
September 30, 2018 0.0234
June 30, 2018 0.0365
March 31, 2018 -0.0776
December 31, 2017 0.0251
September 30, 2017 -0.0152
June 30, 2017 -0.0114
March 31, 2017 -0.0455
December 31, 2016 0.0505
September 30, 2016 -0.0234
June 30, 2016 -0.092
March 31, 2016 -0.0724
September 30, 2015 -0.0431
June 30, 2015 -0.0327
March 31, 2015 -0.0383
December 31, 2014 0.0077
September 30, 2014 -0.0285
June 30, 2014 -0.0349
March 31, 2014 -0.0396
December 31, 2013 -0.0535

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
3-D Matrix Ltd. 0.0141
Healios KK 0.0554
AnGes, Inc. -0.0258
ACADIA Pharmaceuticals, Inc. 0.1822
Alkermes Plc 0.0029